ArticleEMBO molecular medicine2024

Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma.

Simin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.